Anhui Huaheng Biotechnology Past Earnings Performance
Past criteria checks 1/6
Anhui Huaheng Biotechnology has been growing earnings at an average annual rate of 30.7%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 33.2% per year. Anhui Huaheng Biotechnology's return on equity is 15.9%, and it has net margins of 14.1%.
Key information
30.7%
Earnings growth rate
25.3%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 33.2% |
| Return on equity | 15.9% |
| Net Margin | 14.1% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Analysts Just Cut Their EPS Forecasts Substantially
Dec 20
Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Soars 35% But It's A Story Of Risk Vs Reward
Oct 21Here's Why We Think Anhui Huaheng Biotechnology (SHSE:688639) Is Well Worth Watching
Oct 14Slammed 29% Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Screens Well Here But There Might Be A Catch
Sep 05Anhui Huaheng Biotechnology's (SHSE:688639) Profits Appear To Have Quality Issues
Sep 03Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Analysts Just Cut Their EPS Forecasts Substantially
Sep 02Many Would Be Envious Of Anhui Huaheng Biotechnology's (SHSE:688639) Excellent Returns On Capital
Aug 20Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Jul 22Anhui Huaheng Biotechnology Co., Ltd.'s (SHSE:688639) Intrinsic Value Is Potentially 43% Above Its Share Price
Jul 12Is Anhui Huaheng Biotechnology (SHSE:688639) Using Too Much Debt?
Jun 21Take Care Before Jumping Onto Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Even Though It's 27% Cheaper
Jun 05We Ran A Stock Scan For Earnings Growth And Anhui Huaheng Biotechnology (SHSE:688639) Passed With Ease
May 12Earnings Report: Anhui Huaheng Biotechnology Co., Ltd. Missed Revenue Estimates By 37%
Apr 23Anhui Huaheng Biotechnology Co., Ltd.'s (SHSE:688639) Business Is Trailing The Market But Its Shares Aren't
Mar 18Revenue & Expenses Breakdown
How Anhui Huaheng Biotechnology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 2,113 | 299 | 204 | 122 |
| 30 Jun 24 | 2,105 | 408 | 188 | 118 |
| 31 Mar 24 | 2,046 | 443 | 185 | 116 |
| 31 Dec 23 | 1,938 | 449 | 172 | 109 |
| 30 Sep 23 | 1,799 | 423 | 166 | 97 |
| 30 Jun 23 | 1,640 | 382 | 158 | 100 |
| 31 Mar 23 | 1,548 | 346 | 151 | 90 |
| 31 Dec 22 | 1,419 | 320 | 145 | 79 |
| 30 Sep 22 | 1,317 | 283 | 131 | 78 |
| 30 Jun 22 | 1,203 | 235 | 112 | 67 |
| 31 Mar 22 | 1,059 | 192 | 98 | 59 |
| 31 Dec 21 | 954 | 168 | 80 | 53 |
| 30 Sep 21 | 748 | 138 | 58 | 39 |
| 30 Jun 21 | 608 | 118 | 54 | 31 |
| 31 Mar 21 | 523 | 120 | 42 | 28 |
| 31 Dec 20 | 487 | 121 | 43 | 30 |
| 31 Dec 19 | 491 | 126 | 50 | 30 |
| 31 Dec 18 | 421 | 76 | 59 | 22 |
| 31 Dec 17 | 383 | 65 | 33 | 20 |
| 30 Jun 17 | 367 | 72 | 52 | 0 |
| 31 Mar 17 | 339 | 67 | 49 | 0 |
| 31 Dec 16 | 311 | 62 | 46 | 0 |
| 30 Sep 16 | 282 | 51 | 42 | 0 |
| 30 Jun 16 | 253 | 40 | 39 | 0 |
| 31 Mar 16 | 253 | 41 | 37 | 0 |
| 31 Dec 15 | 253 | 43 | 34 | 0 |
| 30 Sep 15 | 249 | 34 | 44 | 0 |
| 30 Jun 15 | 244 | 41 | 35 | 0 |
| 31 Mar 15 | 235 | 40 | 33 | 0 |
| 31 Dec 14 | 225 | 23 | 50 | 0 |
| 30 Sep 14 | 216 | 27 | 38 | 0 |
| 30 Jun 14 | 207 | 30 | 25 | 0 |
| 31 Mar 14 | 190 | 22 | 24 | 0 |
| 31 Dec 13 | 173 | 13 | 22 | 0 |
Quality Earnings: 688639 has a high level of non-cash earnings.
Growing Profit Margin: 688639's current net profit margins (14.1%) are lower than last year (23.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688639's earnings have grown significantly by 30.7% per year over the past 5 years.
Accelerating Growth: 688639's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 688639 had negative earnings growth (-29.3%) over the past year, making it difficult to compare to the Chemicals industry average (-4.7%).
Return on Equity
High ROE: 688639's Return on Equity (15.9%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 06:11 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Anhui Huaheng Biotechnology Co., Ltd. is covered by 9 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Tianhe Wang | China International Capital Corporation Limited |
| Feifei Xu | China Merchants Securities Co. Ltd. |
| Chao Li | Citic Securities Co., Ltd. |